Growth is set to accelerate starting next quarter, powered by its GLP-1 offering. Although the company reported strong second-quarter results and raised its guidance, shares of Hims & Hers Health (HIMS 0.69%) slipped immediately after its earnings announcement. Nonetheless, the stock has been a strong performer this year, up over 80%. Let's take a look at the telehealth company's most recent results, and decide whether it still makes sense to buy the stock on this recent pullback. Surging revenue Hims & Her ...